Anadis Limited, a Melbourne-based biopharmaceutical company, has sign an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Anadis' product, Travelan, in the Canadian market. Travelan is an over-the-counter preparation that reduces the risk of getting the medical condition known as 'Travellers' Diarrhoea' (otherwise known as Delhi Belly, Montezuma's Revenge, Tourist Trots and the Flux etc.). First sales of Travelan in the Canadian market are anticipated in February/March 2006. Valeo Pharma Inc. is a specialty pharmaceutical company that acquires branded pharmaceutical products from partners. Baralex Inc. is a privately-owned international distributor of pharmaceutical products.